3 fantastic ASX shares to buy this month

Here are three highly rated ASX shares…

| More on:
3 asx shares represented by investor holding up 3 fingers

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are a large number of ASX shares to choose from on the Australian share market.

Three that come highly rated are listed below. Here's why these ASX shares are being tipped as buys:

Healius Ltd (ASX: HLS)

The first ASX share to look at is Healius. It is one of Australia's largest pathology and diagnostic imaging providers offering a range of services. Thanks largely to elevated demand for COVID-19 testing, during the first quarter, Healius reported a 43.7% increase in group quarterly revenue over the prior corresponding period to $689.9 million. And with testing demand remaining strong because of the Omicron variant, the company looks well placed to deliver a very strong result in FY 2022.

Morgans is positive on Healius and has an add rating and $5.79 price target on its shares.

Life360 Inc (ASX: 360)

Another ASX share to look at is Life360. It operates in the digital consumer subscription services market and has a focus on products and services for digitally native families. This is where all members of the household are connected by smartphones, which is most families these days. A massive 33.8 million monthly active users are using its app at present, which is underpinning stellar recurring revenue growth. Life360 also has significant opportunities to monetise its user base further in the future through cross and upselling opportunities and acquisitions.

Bell Potter is bullish on Life360. It has a buy rating and $15.25 price target on the company's shares.

SEEK Limited (ASX: SEK)

This job listings company could be another ASX share to buy. Although SEEK was hit hard initially by the pandemic it has bounced back very strongly. SEEK reported a 1% increase in revenue to $1,591 million and a 58% jump in net profit after tax (excluding significant items) to $141 million in FY 2021. Pleasingly, it looks set to build on this in the coming years as the Australian economy recovers from COVID-19.

Credit Suisse is a fan and has an outperform rating and $39.50 price target on its shares.

Motley Fool contributor James Mickleboro owns Life360, Inc. and SEEK Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Life360, Inc. The Motley Fool Australia has recommended SEEK Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

2 ASX growth shares to snap up while they're still down

Brokers see plenty of upside for these mainstay sector picks.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

Why these ASX growth stocks could be much bigger in 2030 than today

These stocks have long growth runways and strong business models.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Growth Shares

3 incredible ASX growth shares to buy and hold forever in 2026

True long-term investing means owning businesses you’d be happy to hold through volatility, uncertainty, and decades of change.

Read more »

Happy work colleagues give each other a fist pump.
Growth Shares

2 shares to buy hand over fist before the ASX 200 soars higher in 2026

These shares are highly rated by brokers for a reason. Here's what you need to know about them.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Experts rate these 2 ASX shares as buys this month!

Leading analysts say these stocks are a buy.

Read more »

Happy healthcare workers in a labs
Technology Shares

Prediction: CSL shares could soar past $270 in 2026

Here's what to expect from the Australian-based global biotechnology company this year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

2 unstoppable ASX 200 stocks to buy in 2026 and hold forever

These blue chips could have very bright futures. Do you own them?

Read more »

A man sees some good news on his phone and gives a little cheer.
Growth Shares

5 incredible ASX growth stocks to buy for 2026

These growth stocks could be well-positioned for the long-term.

Read more »